Page results
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.
-
All GPs are now welcome to use our national Infectious & Tropical Disease Advice and Guidance function on the e-referral system (NHS e-RS)
-
Our outpatient clinics will remain predominantly virtual throughout the COVID-19 pandemic. Please continue to refer via the NHS e-referral service.
-
This information is for UCLH patients with cancer or a blood condition who are being offered a PICC (peripherally inserted central catheter).
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a face-to-face appointment.
-
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.
-
In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.
-
A front page story and patient case study highlight SUMMIT Study early diagnosis outcomes.
File results
-
FOI/2023/0681 - Patient friends and family test supplier
-
FOI/2023/0683 - Electronic Patient Records (EPR)/ Patient Administration System (PAS)
-
FOI/2023/0686 - Hysteroscopy Inpatient and Outpatient pathways
-
FOI/2023/0687 - Information Governance pay grades
-
FOI/2023/0689 - Access to digital test results for patients
-
FOI/2023/0691 - Integrated medicine
-
FOI/2023/0692 - Trust's Five year strategy spend
-
FOI/2023/0696 - Freedom of Information (FOI) requests/ staff details
-
FOI/2023/0698 - Teatment of breast cancer
-
FOI/2023/0699 - Finance/ Procurement/ Estates and Facilities organisation charts